secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2023-08-11T23:59:59+00:00
Accession:  0001171843-23-005273
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics Q2 revenue down 15% to $5.5M, net loss widens; CEO transition, dividend eliminated
--------------------------------------------------------------------------------

- Revenue $5.5M vs $6.5M (-15%); net loss $(726,000) vs $(338,000); EPS $(0.13) vs $(0.06).
- Gross margin improved to 37% from 35% on cost reductions; labor shortage hurt client testing volumes.
- CEO Ray Kubacki retiring Aug 17; Brian Hullinger named President and CEO, pending board appointment.
- Board eliminated dividend to maximize capital for growth initiatives.
- Lawsuit settlement with consultant resulted in non-recurring expense; sum payable over 18 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184323005273/0001171843-23-005273-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184323005273/f8k_081123.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-005273

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer